Report Categories
View AllRecent Articles
View All
Zentek ZTEK Stock Secondary Offering Institutional Selling 20260420
SMSI Smith posts Q4 2025 doubledigit YoY revenue drop and narrow EPS miss shares edge slightly lower today
OmniAb OABI Stock Analysis Undervalued or Overpriced Q4 2025 EPS Misses Views
Is Ouster OUST stock forming a breakout today Q4 2025 Profit Exceeds Views
How sustainable is LeonaBio LONA profit margins Selling Pressure 20260506
Is Virtus ZTR stock expensive on PE Flirts with Support 20260429
iShares Core SP SmallCap ETF IJR Positioned for Potential Outperformance Amid SmallCap Market Rotation
How Heritage Global HGBL benefits from the shifts in its industry Institutional Selling 20260508
Ermenegildo ZGN Tops Q4 2025 Expectations with EPS of 021
Cantaloupe CTLP Stock Consolidating at 1120 Next Move Ahead 20260520
Virtu Financial VIRT Stock Forecast Can 5060 Hold After 096 Drop 20260521
Viridian Therapeutics Prices Upsized 350M Concurrent Public Offerings
Bessent Sees Substantial Disinflation Ahead as Warsh Assumes Fed Leadership
DeepSeek AI Model from China Gains Silicon Valley Acclaim Despite Chip Constraints
SP 500 Edges Higher as Healthcare and Tech Lead Gains
Retail Hiring Surges in April as Consumer Sentiment Clouds
Mistral AI Considers InHouse Chip Development to Cut Costs and Compete with US Rivals
Home Depot Reports Mixed Q1 2026 Results Sales Rise Earnings and Return Metrics Fall
Enterprise Financial Services EFSCP Q1 2026 Earnings Narrow EPS Miss Amid Market Optimism
TRDA Q1 2026 Earnings SmallerThanExpected Loss Offers Cautious Optimism Amid PreRevenue Stage
Bristow Group VTOL Q1 2026 Earnings Earnings Miss Weighs on Investor Sentiment
GBFH Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Declines
MDGL Q1 2026 Earnings NarrowerthanExpected Loss as Rezdiffra Launch Progresses
Voyager Therapeutics Inc VYGR Q1 2026 Earnings Narrowed Loss Meets Optimism in Gene Therapy Pipeline
Titan America SA TTAM Holds Steady as Support and Resistance Define a Tight Range
Odyssey Marine Exploration OMEX Edges Higher as It Tests Key Resistance Zone
Gilead Sciences GILD Edges Higher Modestly as Shares Hold Above Key Support
Sachem Capital Notes SCCG Hold Steady Near Support Amid Modest Decline
Nuveen Preferred Income Opportunities Fund JPC Edges Higher Navigating a YieldDriven Market